TN2013000286A1 - Orally dispersible tablet - Google Patents
Orally dispersible tabletInfo
- Publication number
- TN2013000286A1 TN2013000286A1 TNP2013000286A TN2013000286A TN2013000286A1 TN 2013000286 A1 TN2013000286 A1 TN 2013000286A1 TN P2013000286 A TNP2013000286 A TN P2013000286A TN 2013000286 A TN2013000286 A TN 2013000286A TN 2013000286 A1 TN2013000286 A1 TN 2013000286A1
- Authority
- TN
- Tunisia
- Prior art keywords
- granules
- medicament
- preparation
- dispersible tablet
- disintegrant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Zoology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011227333 | 2011-10-14 | ||
| PCT/JP2012/051279 WO2012099260A1 (fr) | 2011-01-17 | 2012-01-16 | Comprimé dispersible par voie orale |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2013000286A1 true TN2013000286A1 (en) | 2015-01-20 |
Family
ID=46717925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2013000286A TN2013000286A1 (en) | 2011-10-14 | 2013-07-04 | Orally dispersible tablet |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP2765985A1 (fr) |
| JP (1) | JP6061924B2 (fr) |
| TN (1) | TN2013000286A1 (fr) |
| WO (1) | WO2013054582A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112019004896A2 (pt) * | 2016-09-15 | 2019-06-04 | Skintech Life Science Ltd | administração sublingual ou bucal de dim para o tratamento de doenças da pele |
| JP7407364B2 (ja) * | 2019-02-12 | 2024-01-04 | 日本ジェネリック株式会社 | ラメルテオン含有固形製剤 |
| CN110433142A (zh) * | 2019-09-06 | 2019-11-12 | 杭州百诚医药科技股份有限公司 | 一种雷美替胺舌下片及其制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6034239A (en) | 1996-03-08 | 2000-03-07 | Takeda Chemical Industries, Ltd. | Tricyclic compounds, their production and use |
| PT914818E (pt) | 1996-06-14 | 2005-08-31 | Kyowa Hakko Kogyo Kk | Comprimido de desintegracao rapida por via intraoral |
| JP3460538B2 (ja) | 1997-10-08 | 2003-10-27 | 救急薬品工業株式会社 | 速溶性フィルム製剤 |
| WO2001015735A1 (fr) | 1999-08-26 | 2001-03-08 | Takeda Chemical Industries, Ltd. | Matrice adherant a la muqueuse nasale |
| JP4632499B2 (ja) * | 1999-08-26 | 2011-02-16 | 武田薬品工業株式会社 | 鼻粘膜付着マトリックス |
| FR2834890B1 (fr) | 2002-01-23 | 2004-02-27 | Servier Lab | Composition pharmaceutique orodispersible d'agomelatine |
| US20090042861A1 (en) * | 2005-04-04 | 2009-02-12 | Takeda Pharmaceutical Company Limited | Prophylactic or Therapeutic Agent for Depression or Anxiety Disorder |
| FR2894475B1 (fr) | 2005-12-14 | 2008-05-16 | Servier Lab | Composition pharmaceutique orodispersible pour administra- -tion oromucosale ou sublinguale d'agomelatine |
| BRPI0711872A2 (pt) * | 2006-05-22 | 2011-12-06 | Vanda Pharmaceuticals Inc | tratamento para distúrbios depressivos |
| WO2008083204A2 (fr) * | 2006-12-28 | 2008-07-10 | Braincells, Inc. | Modulation de la neurogenèse par des ligands mélatoninergiques |
| JP2008255064A (ja) * | 2007-04-06 | 2008-10-23 | Takeda Chem Ind Ltd | 睡眠障害予防治療剤 |
| JP2009136240A (ja) | 2007-12-10 | 2009-06-25 | Lion Corp | チューインガム組成物 |
| JP5523913B2 (ja) | 2010-04-21 | 2014-06-18 | スタンレー電気株式会社 | 光源装置および照明装置 |
-
2012
- 2012-07-25 WO PCT/JP2012/069535 patent/WO2013054582A1/fr not_active Ceased
- 2012-07-25 JP JP2014517301A patent/JP6061924B2/ja not_active Expired - Fee Related
- 2012-07-25 EP EP12748799.9A patent/EP2765985A1/fr not_active Withdrawn
-
2013
- 2013-07-04 TN TNP2013000286A patent/TN2013000286A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2014528395A (ja) | 2014-10-27 |
| EP2765985A1 (fr) | 2014-08-20 |
| WO2013054582A1 (fr) | 2013-04-18 |
| JP6061924B2 (ja) | 2017-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12013501512A1 (en) | Orally dispersible tablet | |
| BR112013019223A2 (pt) | forma de dosagem para liberação modificada, processo para a fabricação de um comprimido e processo para a fabricação de uma forma de dosagem oral | |
| CO6551722A2 (es) | Composiciones y tabletas farmacéuticas con recubrimiento o compresible y métodos de fabricación | |
| WO2012131463A3 (fr) | Formes pharmaceutiques à libération contrôlée | |
| WO2012174158A3 (fr) | Administration de benzodiazépine | |
| EP2273975B8 (fr) | Solutions pharmaceutiques, procédé de préparation et utilisations thérapeutiques | |
| EP2650124A4 (fr) | Stratifié à structure fine, procédé de préparation d'un stratifié à structure fine et procédé de production d'un stratifié à structure fine | |
| MX2013007057A (es) | Metodos para producir composiciones farmaceuticas estabilizadas de dosis solida que contienen morfinanos. | |
| EP2694269A4 (fr) | Compositions de lignine, procédés de production des compositions, procédés d'utilisations desdites compositions de lignine et produits élaborés de la sorte | |
| WO2008046581A3 (fr) | Composés tétrahydropyrrolopyrazine substitués et leur utilisation dans des médicaments | |
| EP2543061A4 (fr) | Procédé destiné à la production d'un élément conforme, élément conforme et utilisations associées | |
| EP2204229A4 (fr) | Procédé de fabrication d'une émulsion ou d'une dispersion et d'une préparation alimentaire ou d'une préparation pour traitement externe de la peau, et médicament contenant l'émulsion ou dispersion obtenue par ledit procédé | |
| MX355086B (es) | Preparacion de liberacion sostenida de invabradina o sales farmaceuticamente aceptables de la misma. | |
| WO2010102778A3 (fr) | 3-aminoisoxazolopyridines substituées en tant que modulateurs de kcnq 2/3 | |
| WO2011048563A3 (fr) | Comprimés de bétahistine fondant dans la bouche | |
| CL2013001770A1 (es) | Proceso para la fabricacion de productos autoclavado de fibrocemento; y producto autoclavado de fibrocemento. | |
| WO2014177585A3 (fr) | Production biocatalytique d'analogues nucléosidiques en tant que principes actifs pharmaceutiques | |
| CA2863376A1 (fr) | Comprimes gastro-resistants | |
| AU2012319844A8 (en) | Composite structure, packaging material and formed product using same, production methods thereof, and coating liquid | |
| WO2010012459A3 (fr) | Procédé de préparation de sels de solifénacine et inclusion de ces derniers dans des formes pharmaceutiques | |
| TN2013000286A1 (en) | Orally dispersible tablet | |
| CA2863371A1 (fr) | Comprimes de pregabaline gastro-resistants | |
| IL213671A (en) | Pharmaceutical preparations containing alglitazar, a process for their preparation and use for the preparation of medicines | |
| WO2010079045A3 (fr) | Nouveaux sels | |
| MX359529B (es) | Tabletas recubiertas de desintegración rápida. |